Progyny (PGNY) PT Raised to $36 at Canaccord

July 21, 2026 6:43 AM

Canaccord analyst Richard Close raised the price target on Progyny (NASDAQ: PGNY) to $36.00 (from $30.00) while maintaining a Buy rating.

No results found